Topoisomerase inhibitor, Moxifloxacin HCl, Purity ≥98%

Cat. No.: X24-08-YM023

Topoisomerase inhibitor, Moxifloxacin HCl, Purity ≥98%

Synonym: 186826-86-8; Avelox; Avalox; BAY 12-8039; 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid; hydrochloride

  • MDL: MFCD00949117
  • CAS Number: 186826-86-8
  • Compound CID: 101526
Product Size
50 mg; 100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Moxifloxacin HCl, soluble in DMSO and water and insoluble in ethanol, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase.
Molecular Weight
437.9
Molecular Formula
C21H24FN3O4·HCl
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 77 mg/mL (175.84 mM); Water: 53 mg/mL (121.03 mM); Ethanol: insoluble; In vivo: 30% PEG400 + 0.5% Tween80 + 5% propylene glycol, 28 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Moxifloxacin HCl is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of infections such as respiratory tract infections, skin infections, and intra-abdominal infections.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.